Skip to main content

Table 1 Demographic and clinical profile of the inflammatory bowel disease patients and healthy controls

From: The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China

 

    UC

    CD

    IBD

Healthy controls

P value

 

  n = 189(%)

  n = 37(%)

  n = 226(%)

  n = 290(%)

 

Mean age ± SD (yr)

40.81 ± 15.00

38.78 ± 14.14

40.66 ± 14.90

38.08 ± 14.63

0.888

Male/Female

109/80

23/14

132/94

170/120

0.961

Smoking

45 (23.81%)

9 (24.32%)

54 (23.89%)

101 (34.83%)

0.007*

Drinking

75 (39.68%)

12 (32.43%)

87 (38.50%)

133 (45.86%)

0.093

Diet composition

     

 vegetarian food

18 (9.52%)

6 (16.22%)

24 (10.62%)

19 (6.55%)

0.097

 mixed food

171 (90.48%)

31 (83.78%)

202 (89.38%)

271 (93.45%)

 

General state

     

 fever

32 (16.93%)

4 (10.81%)

36 (15.93%)

  

 hemoglobin (g/L)

114.10 ± 23.98

121.22 ± 25.34

115.71 ± 24.37

  

 albumin (g/L)

39.97 ± 5.88

38.12 ± 6.44

39.94 ± 6.04

  

Disease extent

     

 distal colitis

140 (74.07%)

    

 pancolitis

49 (25.93%)

    

 ileal

 

8 (21.62%)

   

 colonic

 

14 (37.84%)

   

 ileocolonic

 

15 (44.11%)

   

Disease severity

     

 mild/moderate

168

30

   

 severe

21 (11.1%)

7 (18.92%)

   

Treatment

     

 ASA/SASP

149 (78.84%)

20 (54.05%)

169 (74.78%)

  

 corticosteroids

47 (24.87%)

8 (21.62%)

55 (24.34%)

  

 immunodepressant

5 (2.65%)

2 (5.41%)

7 (3.10%)

  
  1. CMV, cytomegalovirus; UC, ulcerative colitis; CD, Crohn’s disease; ASA, aminosalicylic acid; SASP, salicylazosulfapyridine.
  2. *indicate significant difference.